Home » Newsletters » BioWorld Science

BioWorld Science

May 31, 2022

View Archived Issues

Novel tricyclic HIV-1 integrase-LEDGF/p75 allosteric inhibitors show improved antiviral activity

Discovery of novel orally bioavailable SERD with enhanced pharmacological properties

NRG Therapeutics receives Biomedical Catalyst award for neurodegenerative disorders

Glycoengineering improves the anti-inflammatory effects of small extracellular vesicles

SLC13A5 inhibitors identified at the Rosalind Franklin University of Medicine and Science

Suzhou Yabao Pharmaceutical Research and Development patents mutant LRRK2 inhibitors

New menin/MLL interaction inhibitors synthesized at Shanghai Euregen Biopharma

Boehringer Ingelheim presents new indoleamine 2,3-dioxygenase 1 inhibitors

New CD73 inhibitors patented by Humanwell Healthcare

PharmEnable and Denali Therapeutics to collaborate in neurodegenerative disease research

RAGE-silencing RNAi suppresses pulmonary allergic inflammation

Cytoplasmic RNA vector expressing anti-CD81 antibodies suppresses experimental arthritis

Studies identify chronic pain mechanisms in skin and spinal cord

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...